Its about providing care that can improve their lives. Moving toward medications In a dramatic shift in pediatric weight-loss options, the Food and Drug Administration approved a GLP-1 medication the daily injectable liraglutide for kids 12 and up in 2020, and a second the weekly injectable semaglutide in 2022
Chronic kidney diseaseassociated pruritus: what is known and its application in children
If you're considering starting Ozempic ( semaglutide ), you may be wondering if its safe, if there are any side effects to know about, and what to expect in the first few weeks of treatment
The clinical case for pairing these medications with nutrition support is written into the label
Sacks FM, Lichtenstein AH, Wu JHY, et al
Pharmaceutical GLP-1 medications provide continuous receptor activation for days between doses